- $3.70bn
- $3.83bn
- $1.39bn
- 66
- 81
- 57
- 77
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 895 | 943 | 933 | 1,050 | 1,098 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 848 | 943 | 1,011 | 1,078 | 1,038 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 393 | -125 | 568 | 659 | 490 |
Provision for Income Taxes | |||||
Net Income After Taxes | 327 | -45.2 | 463 | 524 | 393 |
Net Income Before Extraordinary Items | |||||
Net Income | 327 | -45.2 | 463 | 524 | 393 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 322 | -46.9 | 454 | 516 | 389 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.03 | 3.98 | 5.39 | 5.98 | 4.32 |
Dividends per Share |